Skip to main content

FIREFLY NEUROSCIENCE, INC.

For the period ended Jun 30, 2025. Filed Aug 13, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 30, 2025 · Filed Aug 13, 2025

AIFF$0.91+0.0%Stored close · as of Nov 6, 2026

What changed in Risk Factors?

Read the current filing

The baseline is this issuer’s latest earlier reporting period of the same form that was filed before the current report. A previous 10-Q is a different quarter, not a year-over-year comparison. Amendments are excluded.

Compared 14 previous paragraphs and 11 current paragraphs.

5 unchanged; 2 reworded; 4 added; 7 removed; 0 previous and 0 current paragraphs rearranged.

Tables are not compared: 8 previous and 0 current tables excluded. Dates, whitespace, punctuation and numbering changes are ignored; changes to financial figures remain significant.

A changed paragraph is not evidence that risk increased or decreased. An unchanged paragraph does not establish that risk stayed the same.

Added paragraphs (4)

Current report

Item** 1A. RISK FACTORS

Current report

Item** 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

Current report

Item** 3. DEFAULTS UPON SENIOR SECURITIES

Current report

Item** 4. MINE SAFETY DISCLOSURES
Removed paragraphs (7)

Previous report

We have engaged, and may continue to engage, in strategic acquisitions or transactions, which could have a material adverse effect on our business, results of operations, financial condition and cash flows.

Previous report

Acquisitions involve a number of risks, including diversion of management’s attention, ability to finance theacquisition on attractive terms, failure to retain key personnel or valuable customers, legal liabilities, the need to amortize acquired intangible assets, and intellectual property ownership and infringement risks, any of which could have a material adverse effect on our business, results of operations, financial condition and cash flows. Any additional future acquisitions may also result in the incurrence of indebtedness or the issuance of additional equity securities.

Previous report

We could also experience financial or other setbacks if transactions encounter unanticipated problems, including problems related to governmental approval, execution, integration or underperformance relative to prior expectations. Acquisitions may not result in long-term benefits to us or we may not be able to further develop the acquired business in the manner we anticipated.

Previous report

Following the completion of acquisitions, we may have to rely on the seller to provide administrative and other support, including financial reporting and internal controls, and other transition services to the acquired business for a period of time. There can be no assurance that the seller will do so in a manner that is acceptable to us.

Previous report

We may not realize the anticipated benefits of past or future acquisitions and integration of these acquisitions may disrupt our business.

Previous report

In April 2025, we acquired Evoke Neuroscience Inc ("Evoke"), On April 30, 2025, we completed theacquisition of the Evoke Neuroscience Inc ("Evoke"), which resulted in ouracquisition of the Evoke business and a significant expansion of our business operations and headcount. In the future, we may acquire additional companies, project pipelines, products, or technologies, or enter into joint ventures or other strategic initiatives. Our ability as an organization to integrate acquisitions is unproven. We may not realize the anticipated benefits of our acquisitions or any other futureacquisition or theacquisition may be viewed negatively by customers, financial markets or investors.

Previous report

Anyacquisition has numerous risks, including, but not limited to, the following:
Reworded paragraphs (2)

Previous wording

There are no material changes from the risk factors previously disclosed in Item 1A “Risk Factors” of the 2024 Annual Report with the exception of the Risk Factors added below.

Current wording

There are no material changes from the risk factors previously disclosed in the Company's Registration Statement on Form S-1, as filed with the SEC on July 18, 2025, with the exception of the risk factors added below.

Previous wording

There were no unregistered sales of the Company’s equity securities during the three months ended March 31, 2025, other than those previously reported in a Current Report on Form 8-K.

Current wording

There were no unregistered sales of the Company’s equity securities during the three months ended June 30, 2025, other than those previously reported in a Current Report on Form 8-K and in a registration statement on Form S-1.